Nantahala Capital Management, LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:08 pm Sale | 2025-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management, LLC | 1,953,045 4.710% | -1,232,519 (-38.69%) | Filing |
| 2025-11-14 4:37 pm Purchase | 2025-09-30 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management, LLC | 3,185,564 9.990% | 351,228 (+12.39%) | Filing |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management, LLC | 2,834,336 9.990% | 881,968 (+45.17%) | Filing |
| 2024-02-14 4:51 pm Sale | 2023-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management, LLC | 1,952,368 5.100% | -845,220 (-30.21%) | Filing |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management, LLC | 2,797,588 9.900% | 2,797,588 (New Position) | Filing |